跳至主要内容
临床试验/NL-OMON51309
NL-OMON51309已完成不适用

Minimally-invasive upper extremity versus lower extremity for accessory access sites during transcatheter aortic valve implantation - TAVI XS

Radboud Universitair Medisch Centrum0 个研究点目标入组 238 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
238

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients must be > 18 years old.
  • 2. Written informed consent is obtained from all patients.
  • 3. Planned for transfemoral TAVI procedure.

排除标准

  • 1. Inability to obtain informed consent.
  • 2. Contra-indication for brachial or femoral vein access (temporary pacemaker
  • access site).
  • 3. Contra-indication for radial or femoral artery access (diagnostic access
  • 4. Use of cerebral embolic protection device (CEPD) if this requires an
  • additional (arterial) access site

研究者

相似试验